Home » AIDS Advocates to Gilead: Save More Lives, Price the ‘Quad’ Reasonably
AIDS Advocates to Gilead: Save More Lives, Price the ‘Quad’ Reasonably
A coalition of AIDS advocates, spearheaded by AIDS Healthcare Foundation, have sent a letter today to the CEO of HIV/AIDS drug maker Gilead Sciences — John C. Martin — urging the company not to “decimate ADAP [AIDS Drug Assistance Programs]” by pricing its latest HIV/AIDS drug combination — known as the “Quad” — higher than Gilead’s Atripla, the most prescribed HIV/AIDS medication.
Yahoo! Finance
Yahoo! Finance
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May